Vicor Technologies Gets Patent for State Dependent Drug Development Platform

David H. Fater, CEO of Vicor Technologies, Inc. Tuesday announced the Company received a Notice of Allowance for its U.S. Patent Application No. 10/359,363 for a method of treating ischemia through administration of a biologic identified through Vicor’s state dependent drug discovery platform.
EarthTimes